ampelopsin has been researched along with Cardiotoxicity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, W; Guan, X; Jiang, J; Li, W; Sun, Y; Wang, Y; Xu, C; Yu, X; Zhang, C; Zhao, Q | 1 |
| Guo, H; Lin, H; Lin, N; Lu, W; Meng, L; Ni, T; Sun, Z; Zhang, C; Zhang, J | 1 |
2 other study(ies) available for ampelopsin and Cardiotoxicity
| Article | Year |
|---|---|
The mechanism of rh-endostatin-induced cardiotoxicity and its protection by dihydromyricetin[in vivo/in vitro, C57BL/6 mice, AC16 and hiPSC-CMs].
Topics: Animals; Carcinoma, Non-Small-Cell Lung; Cardiotoxicity; Drug-Related Side Effects and Adverse Reactions; Endostatins; Humans; Induced Pluripotent Stem Cells; Lung Neoplasms; Mice; Mice, Inbred C57BL; Myocytes, Cardiac | 2023 |
Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1.
Topics: Animals; Antibiotics, Antineoplastic; Apoptosis; Cardiotoxicity; Cell Line; Cell Survival; Doxorubicin; Flavonols; Heart; Inflammasomes; Male; Myocardium; Myocytes, Cardiac; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Sirtuin 1; Ventricular Dysfunction, Left | 2020 |